Health-Related Quality of Life in Tuberculosis Patients in Eritrea: Comparison Among Drug-Susceptible and Rifampicin/Multidrug-Resistant Tuberculosis Patients.

Zenawi Zeramariam Araia, Araia Berhane Mesfin, Amanuel Hadgu Mebrahtu, Adiam Ghebreyohanns Tewelde, Asmerom Tesfagiorgis Tewelde, Solyana Ngusbrhan Kidane
Author Information
  1. Zenawi Zeramariam Araia: National TB and Leprosy Control Program, Communicable Disease Control Division, Ministry of Health, Asmara, Eritrea. ORCID
  2. Araia Berhane Mesfin: Communicable Diseases Control Division, Ministry of Health, Asmara, Eritrea.
  3. Amanuel Hadgu Mebrahtu: National TB and Leprosy Control Program, Communicable Disease Control Division, Ministry of Health, Asmara, Eritrea.
  4. Adiam Ghebreyohanns Tewelde: Integrated Disease Surveillance and Response, Ministry of Health, Asmara, Eritrea.
  5. Asmerom Tesfagiorgis Tewelde: Integrated Disease Surveillance and Response, Ministry of Health, Asmara, Eritrea.
  6. Solyana Ngusbrhan Kidane: Health Systems, WHO Country Office for Eritrea, Asmara, Eritrea.

Abstract

BACKGROUND: Despite the negative impact of tuberculosis (TB) on patients' quality of life, TB control programs focus on biological and clinical parameters to manage and monitor TB patients. In our setting, patients' perception of their experience with TB and the impacts of TB on patients' physical, mental, and social wellbeing remain unknown.
OBJECTIVE: The objective of this study was to evaluate the health-related quality of life (HRQOL) among rifampicin/multidrug-resistant TB (RR/MDR-TB) in comparison to drug-susceptible TB (DS-TB) patients in Eritrea.
METHODS: A cross-sectional study was conducted in RR/MDR-TB and DS-TB patients under treatment. Anonymized data collected using the WHOQOL-BREF questionnaire were analyzed using SPSS version 23. Frequency, mean and standard deviation were used to describe the data. Mean group score comparison and relationship between variables were assessed using -test. Domain score was calculated with a mean score of items within each domain and scaled positively, a higher (increasing) score denoting a higher quality of life. Internal consistency was measured using Cronbach's alpha and statistical significance was set at p < 0.05.
RESULTS: A total of 92 patients (46 RR/MDR-TB and 46 DS-TB) participated in the study. Environmental (40.63 ± 10.72) and physical domains (61.80 ±17.18) were the two most affected domains in RR/MDR-TB and DS-TB patients, respectively. The psychological domain was the least affected domain in RR/MDR-TB (48.28 ± 20.83) and DS-TB patients (76.63 ±15.32). RR/MDR-TB patients had statistically lower mean scores in all domains than DS-TB patients.
CONCLUSION: HRQOL was impaired in both groups, but RR/MDR-TB patients had a worse health-related quality of life.

Keywords

References

  1. Acta Med Port. 2015 Jan-Feb;28(1):87-91 [PMID: 25817503]
  2. BMC Infect Dis. 2016 Sep 05;16:470 [PMID: 27595779]
  3. Health Qual Life Outcomes. 2016 Mar 11;14:42 [PMID: 26969306]
  4. PLoS One. 2016 Jun 03;11(6):e0156258 [PMID: 27257990]
  5. Health Qual Life Outcomes. 2019 Aug 16;17(1):142 [PMID: 31420045]
  6. Int J Tuberc Lung Dis. 2015 Dec;19(12):1513-9 [PMID: 26614194]
  7. PLoS One. 2016 Jul 28;11(7):e0159560 [PMID: 27467560]
  8. S Afr Med J. 2013 Oct 11;104(1):24-6 [PMID: 24388081]
  9. Int J Tuberc Lung Dis. 2019 Jan 1;23(1):73-81 [PMID: 30674378]
  10. PLoS One. 2016 May 03;11(5):e0151892 [PMID: 27137914]
  11. Indian J Tuberc. 2009 Oct;56(4):206-12 [PMID: 20469732]
  12. Qual Life Res. 2013 Oct;22(8):2213-35 [PMID: 23232952]
  13. J Public Health Afr. 2014 Dec 18;5(2):366 [PMID: 28299129]
  14. J Trop Med. 2018 Feb 12;2018:2538532 [PMID: 29623094]
  15. Trop Med Health. 2020 May 19;48:34 [PMID: 32476983]
  16. Int J Tuberc Lung Dis. 2004 Sep;8(9):1100-6 [PMID: 15455595]
  17. J Glob Infect Dis. 2019 Jul-Sep;11(3):102-106 [PMID: 31543651]
  18. J Clin Tuberc Other Mycobact Dis. 2019 Sep 20;17:100121 [PMID: 31788563]
  19. Acta Med Iran. 2014;52(6):448-53 [PMID: 25130152]
  20. Front Psychol. 2016 Oct 27;7:1664 [PMID: 27833578]
  21. Eur Respir J. 2020 Aug 6;56(2): [PMID: 32366485]
  22. Health Qual Life Outcomes. 2019 May 31;17(1):94 [PMID: 31151398]
  23. J Infect. 2018 Nov;77(5):357-367 [PMID: 30036607]
  24. Health Qual Life Outcomes. 2009 Feb 18;7:14 [PMID: 19224645]
  25. Clin Med (Lond). 2016 Dec;16(Suppl 6):s79-s91 [PMID: 27956446]
  26. PLoS One. 2017 Apr 20;12(4):e0174605 [PMID: 28426759]
  27. Int J Tuberc Lung Dis. 2021 Jan 1;25(1):43-51 [PMID: 33384044]
  28. Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):a017863 [PMID: 25918181]
  29. Medicine (Baltimore). 2017 Jul;96(28):e7482 [PMID: 28700490]
  30. PLoS One. 2016 Jan 25;11(1):e0147397 [PMID: 26807933]
  31. Int J Infect Dis. 2015 Mar;32:68-75 [PMID: 25809759]

Grants

  1. 001/World Health Organization

Word Cloud

Created with Highcharts 10.0.0TBpatientsRR/MDR-TBDS-TBqualitylifeusingscorepatients'studymeandomaindomainsphysicalhealth-relatedHRQOLcomparisondatahigher4663±affectedTuberculosisPatientsBACKGROUND:DespitenegativeimpacttuberculosiscontrolprogramsfocusbiologicalclinicalparametersmanagemonitorsettingperceptionexperienceimpactsmentalsocialwellbeingremainunknownOBJECTIVE:objectiveevaluateamongrifampicin/multidrug-resistantdrug-susceptibleEritreaMETHODS:cross-sectionalconductedtreatmentAnonymizedcollectedWHOQOL-BREFquestionnaireanalyzedSPSSversion23FrequencystandarddeviationuseddescribeMeangrouprelationshipvariablesassessed-testDomaincalculateditemswithinscaledpositivelyincreasingdenotingInternalconsistencymeasuredCronbach'salphastatisticalsignificancesetp<005RESULTS:total92participatedEnvironmental4010726180±1718tworespectivelypsychologicalleast4828208376±1532statisticallylowerscoresCONCLUSION:impairedgroupsworseHealth-RelatedQualityLifeEritrea:ComparisonAmongDrug-SusceptibleRifampicin/Multidrug-Resistantendmultidrug-resistantpatient-reportedoutcomesub-SaharanAfrica

Similar Articles

Cited By